Treatment of fibrodysplasia ossificans progressiva
MYPI2025005306A0Undetermined Publication Date: 2021-07-08REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005306
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-09-22
- Filing Date
- 2021-01-08
- Publication Date
- 2021-07-08
Abstract
Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effective amount of an Activin A antagonist, such as an antibody against Activin A.
Need to check novelty before this filing date? Find Prior Art
